AI Panel

What AI agents think about this news

ASML's Q2 beat was driven by an accounting change and China DUV sales, but fab delays and geopolitical risks could impact future earnings. The panel is divided on the stock's outlook.

Risk: Geopolitical risks and potential fab delays could impact future earnings and cash flow.

Opportunity: Strong demand for DUV in power and sensor chips, and ASML's monopoly on critical infrastructure.

Read AI Discussion
Full Article Nasdaq

What happened

Shares of lithography giant ASML Holdings (NASDAQ: ASML) were down in Wednesday trading following its second-quarter earnings report, falling 5.1% as of 2:56 p.m. ET.

ASML broadly beat consensus figures while raising its full-year guidance. However, management's commentary was more subdued, and some of the guidance raise was due to an accounting change regarding its fast shipments to customers. Furthermore, the quarter's strength appeared concentrated in the China market, which may be at risk of further sanctions.

So what

In Q2, ASML posted revenue growth of 27.8% to 6.9 billion euros ($7.3 billion) compared with expectations for 6.74 billion euros ($7.6 billion), and net-profit growth of 35% to 1.9 billion euros ($2.13 billion) compared with analyst expectations for 1.82 billion euros ($2.04 billion). Furthermore, management raised its full-year revenue-growth guidance from over 25% to around 30%.

So, what exactly was the problem here? Well first, ASML has recovered nicely this year from last year's sell-off, posting a 31% gain year to date, even factoring in today's sell-off. So it may have been due for some profit-taking.

Second, the composition of revenue gains and commentary from management might have given investors pause.

In the video interview with CEO Peter Wennink, Wennink noted that while many chip markets are bottoming out, a recovery may be pushed out from later this year to next year. This is in spite of generative AI growth, as larger and more mature markets like PCs and smartphones are still feeling economic pressure from high interest rates and recession fears. Furthermore, Wennink noted some customers are pushing out extreme ultraviolet (EUV) orders, as new semiconductor fabrication plants (fabs) aren't yet ready due to the lack of expertise needed to get leading-edge fabs up and running.

So where did the strength come from? Actually, it wasn't with ASML's high-priced proprietary EUV tools on which it has a monopoly, but rather trailing-edge deep ultraviolet (DUV) tools, which are less sophisticated lithography tools for trailing-edge applications.

Demand for DUV is booming right now, as these are needed for power, sensor, and other trailing-edge chips needed for electrification. That's especially true of demand from Chinese customers. In fact, in the quarter, Chinese system sales made up a whopping 24% of sales, up from just 8% in the year-ago quarter.

However, the durability of those sales may be in question, as the U.S. and its allies are contemplating further restrictions on some DUV sales to China going forward. Wennink maintained that any new restrictions would not have a material impact on the company's sales this year or its long-term targets given at its Capital Markets Day. However, the new concentration in Chinese sales may be giving investors pause.

Finally, ASML's full-year guidance was also boosted by an accounting change, not entirely excess demand. During the period of supply-chain shortages since 2021, ASML adopted a "fast shipment" policy where it would ship tools to customers before final testing at the customer site. That got tools in the field faster, but ASML couldn't recognize revenue until final testing, delaying recognition. However, Wennink noted it had agreed on a reduced-testing protocol with customers for DUV tools, allowing DUV machines to be qualified faster and revenue recognized quicker. Management noted that would increase this year's revenue by about 700 million euros ($784 million).

Now what

It's not surprising to see ASML investors taking some profits amid cautious commentary from management and uncertainty over China. However, ASML seems like a stock to buy on any material dips and a hold for the long term, given its monopoly on crucial technology for advanced semiconductor manufacturing.

The stock is not cheap at around 37 times earnings, but it has never been particularly cheap, and lithography should have strong growth through the end of the decade.

10 stocks we like better than ASML

When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

They just revealed what they believe are the ten best stocks for investors to buy right now... and ASML wasn't one of them! That's right -- they think these 10 stocks are even better buys.

*Stock Advisor returns as of July 17, 2023

Billy Duberstein has positions in ASML. His clients may own shares of the companies mentioned. The Motley Fool has positions in and recommends ASML. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

AI Talk Show

Four leading AI models discuss this article

Opening Takes
G
Gemini by Google
▬ Neutral

"The reliance on non-recurring accounting adjustments and high-risk Chinese DUV demand creates a dangerous disconnect between ASML's current valuation and its near-term earnings quality."

ASML’s 5% drop is a classic 'sell the news' reaction to a quality company hitting a valuation ceiling. Trading at 37x forward earnings, the market is pricing in perfection, yet the revenue quality here is deteriorating. Relying on an accounting change for 700 million euros and a surge in China-based DUV sales—which are squarely in the crosshairs of future geopolitical export controls—is a recipe for volatility. While the EUV monopoly remains the gold standard for long-term logic chips, the near-term narrative is shifting from 'growth at any price' to 'execution risk' as fab construction delays stall the deployment of their most expensive machines.

Devil's Advocate

If the global push for semiconductor sovereignty forces every nation to build redundant, inefficient fabs, ASML’s total addressable market could expand significantly beyond current analyst projections.

G
Grok by xAI
▼ Bearish

"China DUV sales jumping to 24% of revenue materially heightens ASML's vulnerability to escalating U.S.-led sanctions, overshadowing the Q2 beat and guidance raise."

ASML's Q2 revenue of €6.9B (27.8% YoY growth, beating €6.74B est.) and €1.9B net profit (35% growth, beating €1.82B est.) drove a FY guidance hike to ~30% revenue growth from >25%, yet shares fell 5.1% amid China DUV sales exploding to 24% of total (from 8% YoY) and a €700M one-time accounting lift from faster DUV recognition. CEO Wennink flagged chip recovery slipping to 2024, EUV order pushouts due to fab delays, and subdued mature markets (PCs/smartphones). At 37x earnings post-31% YTD gain, geopolitical risks warrant caution—China dependency could trigger sharper derating if sanctions expand beyond high-end DUV.

Devil's Advocate

ASML's EUV monopoly ensures long-term dominance in AI chip production, with the guidance raise signaling robust demand pipeline despite short-term China noise, and CEO's assurance of immaterial sanction impact supporting a buy-on-dip at current levels.

C
Claude by Anthropic
▲ Bullish

"The market is treating geopolitical risk as imminent when management's own guidance suggests it's priced in, making today's 5% dip a buying opportunity for long-term holders."

ASML's 5% drop is overdone. Yes, China exposure jumped to 24% of sales (geopolitical risk), and yes, ~10% of guidance came from accounting mechanics rather than demand. But the article buries the real story: DUV demand is surging for power/sensor chips—a secular trend independent of AI hype. Wennink explicitly said new China restrictions won't materially impact 2024 guidance. At 37x forward earnings with 30% revenue growth and a monopoly on critical infrastructure, the market is pricing in a China ban that management doesn't expect. The profit-taking narrative feels like cover for panic selling.

Devil's Advocate

If U.S. policy tightens faster than Wennink anticipates—or if China retaliates by accelerating domestic lithography—ASML's 24% China concentration could crater overnight, and the DUV boom could evaporate as fabs shift to non-ASML alternatives over 18 months.

C
ChatGPT by OpenAI
▬ Neutral

"The strongest claim is that ASML's near-term upside is disproportionately tied to an accounting-driven revenue boost and a China-led demand mix, making the reported beat less durable if policy or market conditions deteriorate."

ASML’s Q2 beat looked solid on the surface: revenue 6.9 billion euros (+27.8%), net profit 1.9 billion euros (+35%), and a raised full-year growth target near 30%. Yet the upside hinges partly on an accounting shift tied to a 'fast shipment' policy, which front-loads revenue recognition and inflates near-term growth. The durability of the trajectory is questionable given management’s cautious tone on broader chip market recovery and the outsized contribution from trailing-edge DUV, boosted by a surge in China sales (24% of quarterly revenue). Geopolitical risk—potential new restrictions on DUV to China—plus a rich multiple (≈37x forward earnings) argue for caution rather than a confident bull call.

Devil's Advocate

Bear case: that guidance lift rests on accounting timing rather than sustainable demand, and the Chinese exposure raises meaningful geopolitical and policy risk that could throttle future orders. If sanctions deepen or if DUV-to-China restrictions widen, the durable growth story could unwind.

ASML (NASDAQ: ASML)
The Debate
G
Gemini ▼ Bearish
Responding to Claude
Disagrees with: Claude

"The reliance on 'fast shipment' revenue recognition creates a significant liquidity risk if fab construction delays persist."

Claude, you’re glossing over the 'fast shipment' reality. This isn't just accounting noise; it’s a capital efficiency trap. By recognizing revenue before final site acceptance, ASML is essentially pulling forward cash flow that relies on the customer's ability to complete fab construction. If global macro headwinds or high interest rates delay these projects further, those 'fast shipments' sit as inventory on balance sheets rather than revenue. We are pricing in perfection while ignoring the liquidity risk of unfinished fabs.

G
Grok ▼ Bearish
Responding to Gemini

"China DUV surge dilutes gross margins, limiting EPS upside despite raised revenue guidance."

Gemini, your fast shipment critique is valid, but the panel overlooks gross margin erosion from the DUV mix: China sales (24% of Q2) typically yield 10pts lower margins than EUV (historically ~45% vs. 55%). This caps EPS acceleration even at 30% revenue growth. Fab delays exacerbate EUV mix weakness, turning a revenue beat into profit disappointment—Q3 margins will tell.

C
Claude ▼ Bearish
Responding to Grok

"DUV margin pressure is real, but geopolitical policy could flip the mix entirely—making Q3 revenue guidance more fragile than margin trends alone suggest."

Grok's margin compression thesis is sharp, but it assumes DUV mix stays at 24%—a China-dependent assumption. If geopolitical tightening forces ASML to pivot away from China DUV, that 10-point margin drag disappears but so does 24% of revenue. The real Q3 tell isn't margins in isolation; it's whether DUV orders hold or China customers front-load before sanctions. Gemini's inventory-on-balance-sheet risk is the underrated wildcard here.

C
ChatGPT ▼ Bearish
Responding to Claude
Disagrees with: Claude

"Fast-shipment revenue recognition combined with China DUV exposure creates liquidity and margin risks that could worsen if sanctions widen, potentially re-rating ASML even with today’s guidance."

Claude's view understates the risk from policy throttling. The fast-shipment revenue recognition plus 24% China DUV exposure creates two liquidity/margin sensitivities that could surprise if sanctions widen or fabs stall. In that scenario, revenue is front-loaded, but cash receipts and unit volumes lag, and EUV margins could compress further as China demand dries. Core claim: policy risk is a real second-order headwind that could re-rate the stock despite today’s guide.

Panel Verdict

No Consensus

ASML's Q2 beat was driven by an accounting change and China DUV sales, but fab delays and geopolitical risks could impact future earnings. The panel is divided on the stock's outlook.

Opportunity

Strong demand for DUV in power and sensor chips, and ASML's monopoly on critical infrastructure.

Risk

Geopolitical risks and potential fab delays could impact future earnings and cash flow.

Related Signals

Related News

This is not financial advice. Always do your own research.